126 related articles for article (PubMed ID: 4147336)
1. [Salbutamol in chronic bronchial asthma].
Blankstein A; Spitzer S
Harefuah; 1973 Jun; 84(12):655-8. PubMed ID: 4147336
[No Abstract] [Full Text] [Related]
2. [Effects of a beta-adrenergic stimulant: Salbutamol, on spontaneous or induced bronchial obstruction in asthma].
Orehek J; Gayrard P; Charpin J
Mars Med; 1972; 109(11):713-7. PubMed ID: 4145413
[No Abstract] [Full Text] [Related]
3. Stepwise therapy of bronchial asthma: the role of beta-adrenergic agonists.
Nelson HS
Ann Allergy; 1985 Apr; 54(4):289-93. PubMed ID: 2858995
[No Abstract] [Full Text] [Related]
4. Comparative study of a new beta-adrenergic stimulant in asthma: salbutamol.
Gayrard P; Orehek J; Charpin J
Postgrad Med J; 1971 Mar; 47():Suppl:46-50. PubMed ID: 4396720
[No Abstract] [Full Text] [Related]
5. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
Van Der Straeten M; Lamont H; Pauwels R; Tasson J
Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
[No Abstract] [Full Text] [Related]
6. [Long-term drug therapy of bronchial asthma in childhood and adolescence].
Berdel D
Schweiz Rundsch Med Prax; 1987 May; 76(21):586-91. PubMed ID: 2885909
[No Abstract] [Full Text] [Related]
7. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
Kokubu H
Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
[TBL] [Abstract][Full Text] [Related]
8. Practical therapeutics current concepts in management of bronchial asthma.
Obel AO
East Afr Med J; 1981 May; 58(5):311-7. PubMed ID: 6116589
[No Abstract] [Full Text] [Related]
9. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
[No Abstract] [Full Text] [Related]
10. [Bronchial asthma: factors which contribute to "intractable asthma" and approach to new treatments, from the standpoint of the bronchial pathophysiology].
Satake T
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Sep; 23(9):971-80. PubMed ID: 2869175
[No Abstract] [Full Text] [Related]
11. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
Shim C
Clin Chest Med; 1984 Dec; 5(4):659-68. PubMed ID: 6151440
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol for the treatment of asthma.
Weinberger M
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
[No Abstract] [Full Text] [Related]
13. Bronchial asthma.
Criep LH
Del Med J; 1984 Jan; 56(1):11-6. PubMed ID: 6141957
[No Abstract] [Full Text] [Related]
14. Salmeterol response and beta(2)-adrenergic receptor genotype.
Jackson C; Lipworth B
J Allergy Clin Immunol; 2007 Jul; 120(1):217-8; author reply 219-20. PubMed ID: 17399780
[No Abstract] [Full Text] [Related]
15. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
Dano P; Falholt W
Ugeskr Laeger; 1971 Apr; 133(15):685-8. PubMed ID: 4396922
[No Abstract] [Full Text] [Related]
16. [Receptor pharmacology (2): Developing trends in receptor pharmacology. Adrenergic bronchodilators].
Svedmyr N
Lakartidningen; 1978 Nov; 75(44):4019-22. PubMed ID: 29998
[No Abstract] [Full Text] [Related]
17. [Asthma: current therapeutic approach].
Bononi F; Mazzone M; Portale G; Forte P; Falcone C; Silveri NG
Recenti Prog Med; 2005 Oct; 96(10):494-8. PubMed ID: 16491774
[TBL] [Abstract][Full Text] [Related]
18. Beta 2-agonist bronchodilators--advances versus controversies.
O'Donnell SR
Proc West Pharmacol Soc; 1993; 36():323-7. PubMed ID: 8104346
[No Abstract] [Full Text] [Related]
19. Asthma.
Pincus RC
Aust Fam Physician; 1985 Mar; 14(3):187-90. PubMed ID: 2859847
[No Abstract] [Full Text] [Related]
20. Beta-agonists in the treatment of asthma in France.
Michel FB; Even P; Clauzel AM
Bull Eur Physiopathol Respir; 1985; 21(5):7s-11s. PubMed ID: 2865995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
